🔎 Trials Near Me

Beranda › Penyakit Alzheimer › Connecticut

Uji klinis Penyakit Alzheimer di Connecticut

12 studi untuk Penyakit Alzheimer mencari peserta di lokasi di Connecticut.

Kota di Connecticut

Teks studi resmi (Bahasa Inggris)

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
Menerima pesertaFase 2
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589595

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • University of Connecticut Health Center, Farmington
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06585787

Music for Pain and Dementia

  • Connecticut Mental Health Clinic, New Haven
Menerima peserta
Usia 50 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07602283

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Yale University, New Haven
Menerima pesertaFase 3
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07177352

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  • Local Institution - 2632, Norwalk
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07011745

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

  • Yale University PET Center, New Haven
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06999434

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  • Yale University, Alzheimer's Disease Research Unit ( Site 1059), New Haven
Menerima pesertaFase 2
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07033494

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Yale University School of Medicine - Section of Cardiology, New Haven
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • Yale University School of Medicine, New Haven
Menerima pesertaFase 2/3Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT06647498

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • Yale University School of Medicine, New Haven
Menerima pesertaFase 2/3Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05552157

Neurologic Stem Cell Treatment Study

  • MD Stem Cells, Westport
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT02795052

Evaluation of a Mobile App Program for Coping With Cancer

  • Smilow Cancer Hospital, New Haven
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT06923501

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.